PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
MeVis Medical Solutions AG (M3V.DE)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

DE000A0LBFE4

Sector

Healthcare

Highlights

Market Cap

€46.23M

Total Revenue (TTM)

€4.39M

Gross Profit (TTM)

€1.73M

EBITDA (TTM)

€1.18M

Year Range

€22.80 - €26.80

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of €10,000 in MeVis Medical Solutions AG, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-10.00%-5.00%0.00%5.00%10.00%15.00%SeptemberOctoberNovemberDecember2025February
-0.77%
16.03%
M3V.DE (MeVis Medical Solutions AG)
Benchmark (^GSPC)

Returns By Period

MeVis Medical Solutions AG had a return of 0.79% year-to-date (YTD) and 7.33% in the last 12 months. Over the past 10 years, MeVis Medical Solutions AG had an annualized return of 10.33%, while the S&P 500 had an annualized return of 11.32%, indicating that MeVis Medical Solutions AG did not perform as well as the benchmark.


M3V.DE

YTD

0.79%

1M

0.79%

6M

0.00%

1Y

7.33%

5Y*

-2.95%

10Y*

10.33%

^GSPC (Benchmark)

YTD

3.97%

1M

4.66%

6M

10.32%

1Y

22.29%

5Y*

12.63%

10Y*

11.32%

*Annualized

Monthly Returns

The table below presents the monthly returns of M3V.DE, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20250.79%0.79%
2024-4.76%5.83%2.31%2.40%3.12%0.00%-3.03%-2.34%-8.00%6.09%0.00%3.28%3.95%
20231.13%1.12%-1.10%-11.17%-1.26%-3.18%2.63%-0.00%-9.62%-5.67%-12.03%7.69%-28.81%
20222.55%1.86%3.59%0.00%1.21%1.80%-2.94%-0.61%4.27%2.34%-4.57%5.99%16.08%
20213.16%-1.84%3.04%2.50%0.00%0.61%0.61%1.20%-2.98%-1.23%-1.24%-1.26%2.39%
20201.32%3.27%-11.39%7.86%19.21%4.35%-2.73%-2.81%-8.09%6.29%-1.78%-4.82%7.39%
20194.38%1.80%-5.39%-1.28%-6.49%2.78%0.68%1.34%-1.32%0.00%1.34%-0.00%-2.70%
2018-0.54%-2.03%0.51%-2.12%-0.54%-1.09%-1.10%-3.89%-0.58%2.91%2.26%-11.60%-17.09%
2017-0.53%1.21%4.49%-2.43%-1.79%-0.88%-0.56%3.81%1.72%0.36%1.46%-0.53%6.25%
20160.00%4.08%-0.84%5.63%4.34%7.85%4.21%4.38%15.81%13.64%-4.40%-2.69%63.35%
20150.28%-0.28%2.84%17.40%-0.41%3.54%3.18%1.64%-2.48%-0.24%2.37%2.13%32.80%
2014-32.39%6.21%5.61%1.45%-2.13%-10.96%5.53%-1.69%5.26%-2.90%11.05%11.93%-11.62%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of M3V.DE is 18, meaning it’s performing worse than 82% of other stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of M3V.DE is 1818
Overall Rank
The Sharpe Ratio Rank of M3V.DE is 1313
Sharpe Ratio Rank
The Sortino Ratio Rank of M3V.DE is 1414
Sortino Ratio Rank
The Omega Ratio Rank of M3V.DE is 1212
Omega Ratio Rank
The Calmar Ratio Rank of M3V.DE is 2525
Calmar Ratio Rank
The Martin Ratio Rank of M3V.DE is 2828
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for MeVis Medical Solutions AG (M3V.DE) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
The chart of Sharpe ratio for M3V.DE, currently valued at -0.66, compared to the broader market-2.000.002.004.00-0.661.69
The chart of Sortino ratio for M3V.DE, currently valued at -0.81, compared to the broader market-6.00-4.00-2.000.002.004.006.00-0.812.29
The chart of Omega ratio for M3V.DE, currently valued at 0.88, compared to the broader market0.501.001.502.000.881.31
The chart of Calmar ratio for M3V.DE, currently valued at -0.36, compared to the broader market0.002.004.006.00-0.362.57
The chart of Martin ratio for M3V.DE, currently valued at -0.83, compared to the broader market0.0010.0020.0030.00-0.8310.46
M3V.DE
^GSPC

The current MeVis Medical Solutions AG Sharpe ratio is -0.66. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of MeVis Medical Solutions AG with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00SeptemberOctoberNovemberDecember2025February
-0.66
1.89
M3V.DE (MeVis Medical Solutions AG)
Benchmark (^GSPC)

Dividends

Dividend History

MeVis Medical Solutions AG provided a 3.74% dividend yield over the last twelve months, with an annual payout of €0.95 per share.


0.00%1.00%2.00%3.00%4.00%€0.00€0.20€0.40€0.60€0.80€1.002015201620172018201920202021202220232024
Dividends
Dividend Yield
PeriodTTM2024202320222021202020192018201720162015
Dividend€0.95€0.95€0.00€0.95€0.95€0.95€0.95€0.95€0.71€0.95€0.04

Dividend yield

3.74%3.77%0.00%2.68%3.03%3.01%3.15%2.97%1.80%2.50%0.17%

Monthly Dividends

The table displays the monthly dividend distributions for MeVis Medical Solutions AG. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2025€0.00€0.00€0.00
2024€0.00€0.00€0.95€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.95
2023€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.00
2022€0.00€0.00€0.95€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.95
2021€0.00€0.00€0.95€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.95
2020€0.00€0.00€0.00€0.00€0.00€0.95€0.00€0.00€0.00€0.00€0.00€0.00€0.95
2019€0.00€0.00€0.95€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.95
2018€0.00€0.00€0.95€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.95
2017€0.00€0.00€0.71€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.71
2016€0.00€0.00€0.00€0.00€0.00€0.95€0.00€0.00€0.00€0.00€0.00€0.00€0.95
2015€0.04€0.00€0.00€0.00€0.00€0.00€0.00€0.04

Dividend Yield & Payout


Dividend Yield
100.0%200.0%300.0%400.0%3.7%
MeVis Medical Solutions AG has a dividend yield of 3.74%, which is quite average when compared to the overall market.
Payout Ratio
200.0%400.0%600.0%800.0%30.1%
MeVis Medical Solutions AG has a payout ratio of 30.06%, which is quite average when compared to the overall market. This suggests that MeVis Medical Solutions AG strikes a balance between reinvesting profits for growth and paying dividends to shareholders.

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-40.00%-30.00%-20.00%-10.00%0.00%SeptemberOctoberNovemberDecember2025February
-37.01%
-0.70%
M3V.DE (MeVis Medical Solutions AG)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the MeVis Medical Solutions AG. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the MeVis Medical Solutions AG was 95.01%, occurring on Nov 18, 2011. The portfolio has not yet recovered.

The current MeVis Medical Solutions AG drawdown is 37.01%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-95.01%Nov 19, 2007931Nov 18, 2011

Volatility

Volatility Chart

The current MeVis Medical Solutions AG volatility is 2.66%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


1.00%2.00%3.00%4.00%5.00%6.00%7.00%SeptemberOctoberNovemberDecember2025February
2.66%
3.99%
M3V.DE (MeVis Medical Solutions AG)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of MeVis Medical Solutions AG over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Valuation

The Valuation section provides an assessment of the market value of MeVis Medical Solutions AG compared to its peers in the Health Information Services industry.


PE Ratio
100.0200.0300.00.0
The chart displays the price to earnings (P/E) ratio for M3V.DE in comparison to other companies of the Health Information Services industry. Currently, M3V.DE has a PE value of 0.0. This PE value is considered to be low compared to the rest of the industry.
PEG Ratio
0.02.04.06.00.0
The chart displays the price to earnings to growth (PEG) ratio for M3V.DE in comparison to other companies of the Health Information Services industry. Currently, M3V.DE has a PEG value of 0.0. This PEG ratio falls in the average range for the industry.

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for MeVis Medical Solutions AG.


Loading data...

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab